ReviewJournal of clinical medicine2022

Effectiveness and Safety of Apixaban in over 3.9 Million People with Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Benjamin J R Buckley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.